HEC Pharmaceutical
Dong Yang Guang Park, Shangsha, Chang’an
Dongguan
Guangdong
523871
China
Tel: 86-769-85315888-2548
Fax: 86-769-85370255
Website: http://www.hecpharm.com
Email: bd@hecpharm.com
About HEC Pharmaceutical
HEC Pharm was founded in 2002, which is one of the famous pharmaceutical enterprise with the best R&D strength in China. HEC pharm have one of the most outstanding pipelines on 5 therapeutic areas in China: hepatitis, oncology, cardiovascular, diabetes, and neurology. A developed technology platform was established for new molecule, generics and bio-similar in HEC. A group of medicines have been launched in China, US and EU. Nowadays, HEC has turned out to be a leading pharmaceutical company in innovative and globalization in China.YEAR FOUNDED:
1992
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products
5 articles about HEC Pharmaceutical
-
In addition to patent cases, partnerships and pledging money to global tropical disease efforts, Novartis scored a win on a combo-treatment for solid tumors.
-
Novartis' win in the patent dispute over its drug, Gilenya, was short-lived after a U.S. appeals court reversed its 2020 ruling vs. HEC Pharm's attempt to create a generic version.
-
HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity
4/12/2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, announced it will design, manufacture, and install multiple 4,000L fermenter trains for HEC Pharm’s manufacturing site in Guangzhou, China.
-
Shenzhen's HEC Pharm Invests in U.S. Novel Imaging Contrast Company
1/9/2018
East Sunshine Foresight Fund will make a "series of investments" of unspecified size in Enlyton, a Columbus, Ohio company developing novel imaging contrast agents.
-
TaiGen Biotechnology And HEC Pharmaceutical Executed Equity Purchase Agreement For Their HCV Joint Venture
3/27/2017